Potential advantages of PAS ports in pediatric patients with hemophilia and high titer inhibitors.

被引:0
|
作者
Heisel, MA
Nelson, SC
Osip, JM
机构
[1] UNIV MINNESOTA HOSP & CLIN,CTR COMPREHENS HEMOPHILIA,MINNEAPOLIS,MN
[2] CHILDRENS HLTH CARE,MINNEAPOLIS,MN
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:3480 / 3480
页数:1
相关论文
共 50 条
  • [31] Preliminary observations from the European study on orthopedic status (ESOS) in hemophilia patients with inhibitors.
    Morfini, Massimo
    Haya, Saturnino
    Pollmann, Hartmut
    Siegmund, Berthold
    Stieltjes, Natalie
    Dolan, Gerry
    Ludlam, Christopher
    BLOOD, 2006, 108 (11) : 309A - 309A
  • [32] Large deletion mutations are linked with hemophilia inhibitors of high titer and short tolerance induction.
    Ragni, MV
    Trucco, M
    Jaworski, K
    Yan, J
    Feng, J
    Hashimi, H
    Hill, KA
    Sommer, SS
    BLOOD, 2003, 102 (11) : 162A - 162A
  • [33] Prophylactic use of rFVIIa for hemophilia B patient with high-titer inhibitors - case report
    Kovalova, Z.
    Grutupa, M.
    Cebura, E.
    Vishnevska-Preciniece, Z.
    Medne, G.
    HAEMOPHILIA, 2013, 19 : 65 - 65
  • [34] Conservative therapy for spinal epidural hematoma in a child with hemophilia A with high-titer VIII inhibitors
    Wang, Guige
    Wang, Shengru
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2021, 49 (02)
  • [35] RFVIIa prophylaxis for hemophilia B with recurrent high-titer inhibitors: a single patient experience
    Kovalova, Z.
    Grutupa, M.
    Cebura, E.
    Vishnevska-Preciniece, Z.
    Nikulshin, S.
    Medne, G.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 1088 - 1088
  • [36] Successful treatment of high titer inhibitors in mild hemophilia a with avoidance of factor VIII and immunosuppressive therapy
    Robbins, D
    Kulkarni, R
    Gera, R
    Scott-Emuakpor, AB
    Bosma, K
    Penner, JA
    AMERICAN JOURNAL OF HEMATOLOGY, 2001, 68 (03) : 184 - 188
  • [37] Modeling Costs and Outcomes Associated with a Treatment Algorithm for Problem Bleeding Episodes in Patients with Severe Hemophilia A and High-Titer Inhibitors
    Bonnet, Patrick
    Gringeri, Alessandro
    Gomperts, Edward
    Leissinger, Cindy Anne
    d'Oiron, Roseline
    Teitel, Jerome
    Young, Guy
    Franklin, Meg
    Ewenstein, Bruce
    Berntorp, Erik
    AMERICAN HEALTH AND DRUG BENEFITS, 2011, 4 (04): : 219 - 228
  • [38] Successful of Immune Tolerance Induction (R-ITI) with Simoctocog Alfa (rhFVIII) in Hemophilia a Patients and High-Titer Inhibitors
    Zanon, Ezio
    Pasca, Samantha
    Marino, Renato
    Molinari, Angelo Claudio
    BLOOD, 2018, 132
  • [39] Screening practices for late effects in pediatric patients on tyrosine kinase inhibitors.
    Smith, Stephanie M.
    Sabnis, Himalee S.
    Lewis, Rebecca Williamson
    Effinger, Karen Elizabeth
    Bergsagel, Daniel John
    Patterson, Briana
    Mertens, Ann C.
    Sakamoto, Kathleen
    Schapira, Lidia
    Castellino, Sharon M.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [40] Long-term outcomes of patients with severe hemophilia A and high titer inhibitors with partial tolerance after immune tolerance induction
    Batsuli, Glaivy
    Meeks, Shannon
    Sidonio, Robert
    HAEMOPHILIA, 2018, 24 : 48 - 49